{
    "nct_id": "NCT05554302",
    "official_title": "Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis",
    "inclusion_criteria": "1. Age ≥ 18 years\n2. Performance status, Eastern Cooperative Oncology Group (ECOG) 0-3\n3. Radiographic diagnosis of brain metastasis\n4. Patient planned for surgical intervention for at least 1 metastasis\n5. Patient planned for postoperative SRS\n\nMale or female patients of reproductive potential need to employ two highly effective and acceptable forms of contraception for at least 4 weeks prior to screening and agreement to use such a method during study participation and for an additional 1 week after post-treatment 18F-Fluciclovine PET/CT. Highly effective and acceptable forms of contraception are:\n\n* Male condom plus spermicide\n* Cap plus spermicide\n* Diaphragm plus spermicide\n* Copper T\n* Progesterone T\n* Levonorgestrel-releasing intrauterine system (e.g., Mirena®)\n* Implants\n* Hormone shot or injection\n* Combined pill\n* Mini-pill\n* Patch\n\nPostmenopausal people on the study (that will not need contraception) is defined as at least one of the following:\n\n* Amenorrhoeic for 1 year or more following cessation of exogenous hormonal treatments\n* Luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels in the postmenopausal range for women under 50\n* Radiation-induced oophorectomy with last menses > 1 year ago\n* Chemotherapy-induced menopause with >1 year interval since last menses\n* Surgical sterilization (bilateral oophorectomy or hysterectomy).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Prior anaphylactic reaction to 18F-Fluciclovine\n2. Evidence of leptomeningeal disease\n3. Prior whole-brain radiation therapy\n4. Contraindication to MRI (e.g., due to safety reasons, such as presence of a pacemaker)\n5. Pregnant at the expected time of 18F-fluciclovine administration\n6. Expecting to be breastfeeding at the time of 18F-Fluciclovine and unwilling to stop breast-feeding for 24 hours. Temporary cessation of breastfeeding 24 hours after the time of imaging is allowed.",
    "miscellaneous_criteria": ""
}